KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $16.0 million.

  • Vir Biotechnology's Other Non-Current Assets rose 15040.74% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 15040.74%. This contributed to the annual value of $12.1 million for FY2024, which is 283.67% down from last year.
  • Latest data reveals that Vir Biotechnology reported Other Non-Current Assets of $16.0 million as of Q3 2025, which was up 15040.74% from $95.2 million recorded in Q2 2025.
  • Vir Biotechnology's 5-year Other Non-Current Assets high stood at $95.2 million for Q2 2025, and its period low was $6.4 million during Q2 2024.
  • Moreover, its 5-year median value for Other Non-Current Assets was $7.0 million (2021), whereas its average is $17.3 million.
  • In the last 5 years, Vir Biotechnology's Other Non-Current Assets plummeted by 2545.35% in 2023 and then skyrocketed by 139544.45% in 2025.
  • Over the past 5 years, Vir Biotechnology's Other Non-Current Assets (Quarter) stood at $7.0 million in 2021, then dropped by 5.0% to $6.7 million in 2022, then surged by 86.43% to $12.4 million in 2023, then decreased by 2.84% to $12.1 million in 2024, then skyrocketed by 32.55% to $16.0 million in 2025.
  • Its last three reported values are $16.0 million in Q3 2025, $95.2 million for Q2 2025, and $94.4 million during Q1 2025.